41. Tissue inhibitor of metalloproteinases-1 induces a pro-tumourigenic increase of miR-210 in lung adenocarcinoma cells and their exosomes.
Cui H, Seubert B, Stahl E, Dietz H, Reuning U, Moreno-Leon L, Ilie M, Hofman P, Nagase H, Mari B, Krüger A
Oncogene. 2014 Sep 29.
PMID: 25263437 [PubMed - as supplied by publisher]
42. Short-term follow-up of disc cell therapy in a porcine nucleotomy model with an albumin-hyaluronan hydrogel: in vivo and in vitro results of metabolic disc cell activity and implant distribution.
Omlor GW, Fischer J, Kleinschmitt K, Benz K, Holschbach J, Brohm K, Anton M, Guehring T, Richter W
Eur Spine J. 2014 Sep .
PMID: 24801573 [PubMed - in process]
43. Stefin B deficiency reduces tumor growth via sensitization of tumor cells to oxidative stress in a breast cancer model.
Butinar M, Prebanda MT, Rajković J, Jerič B, Stoka V, Peters C, Reinheckel T, Krüger A, Turk V, Turk B, Vasiljeva O
Oncogene. 2014 Jun 26.
PMID: 23955077 [PubMed - in process]
44. Gene-activated matrices for bone and cartilage regeneration in arthritis (GAMBA).
Hum Gene Ther Clin Dev. 2014 Jun .
PMID: 24933564 [PubMed - in process]
45. Stem cells and basic fibroblast growth factor failed to improve tendon healing: an in vivo study using lentiviral gene transfer in a rat model.
Kraus TM, Imhoff FB, Wexel G, Wolf A, Hirsch D, Lenz L, Stöckle U, Buchmann S, Tischer T, Imhoff AB, Milz S, Anton M, Vogt S
J Bone Joint Surg Am. 2014 May 7.
PMID: 24806013 [PubMed - in process]
46. Transfer of MHC-class-I molecules among liver sinusoidal cells facilitates hepatic immune surveillance.
Schölzel K, Schildberg FA, Welz M, Börner C, Geiger S, Kurts C, Heikenwälder M, Knolle PA, Wohlleber D
J Hepatol. 2014 Sep .
PMID: 24798625 [PubMed - in process]
47. The stem cell factor SOX2 regulates the tumorigenic potential in human gastric cancer cells.
Hütz K, Mejías-Luque R, Farsakova K, Ogris M, Krebs S, Anton M, Vieth M, Schüller U, Schneider MR, Blum H, Wagner E, Jung A, Gerhard M
Carcinogenesis. 2014 Apr .
PMID: 24325912 [PubMed - in process]
48. IL-6 trans-signaling-dependent rapid development of cytotoxic CD8+ T cell function.
Böttcher JP, Schanz O, Garbers C, Zaremba A, Hegenbarth S, Kurts C, Beyer M, Schultze JL, Kastenmüller W, Rose-John S, Knolle PA
Cell Rep. 2014 Sep 11.
PMID: 25199826 [PubMed - in process]
49. Opposing role of Notch1 and Notch2 in a Kras(G12D)-driven murine non-small cell lung cancer model.
Baumgart A, Mazur PK, Anton M, Rudelius M, Schwamborn K, Feuchtinger A, Behnke K, Walch A, Braren R, Peschel C, Duyster J, Siveke JT, Dechow T
Oncogene. 2014 Feb 10.
PMID: 24509876 [PubMed - as supplied by publisher]
50. Systematic comparison of peptidic proteasome inhibitors highlights the α-ketoamide electrophile as an auspicious reversible lead motif.
Stein ML, Cui H, Beck P, Dubiella C, Voss C, Krüger A, Schmidt B, Groll M
Angew Chem Int Ed Engl. 2014 Feb 3.
PMID: 24403024 [PubMed - in process]